Here's the live share price of Sai Life Science along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sai Life Science | -6.67 | 28.14 | 24.45 | 60.38 | 107.31 | 32.75 | 18.53 |
| Sun Pharmaceutical Industries | -1.25 | 7.30 | -0.22 | -1.73 | 6.40 | 16.38 | 18.82 |
| Divi's Laboratories | -2.17 | 21.78 | 28.72 | 62.01 | 70.96 | 44.47 | 18.24 |
| Torrent Pharmaceuticals | -2.63 | 1.93 | -6.77 | 5.54 | 22.27 | 29.99 | 27.20 |
| Laurus Labs | -4.64 | 12.59 | 27.98 | 74.96 | 130.82 | 84.81 | 36.96 |
| Zydus Lifesciences | 0.41 | 7.37 | 6.98 | 20.56 | 28.74 | 23.40 | 20.87 |
| Dr. Reddy's Laboratories | 1.45 | 12.40 | 18.25 | 4.85 | 12.26 | 7.59 | 8.37 |
| Cipla | 0.21 | 6.69 | -0.83 | -0.46 | -6.25 | 4.43 | 9.74 |
| Mankind Pharma | -0.64 | 17.23 | 10.46 | 5.75 | 18.70 | 9.45 | 13.14 |
| Aurobindo Pharma | -1.32 | 11.52 | 9.92 | 19.93 | 45.29 | 21.74 | 23.01 |
| Lupin | -2.58 | 0.78 | -11.51 | -12.61 | -3.82 | 18.01 | 16.97 |
| Glenmark Pharmaceuticals | -0.75 | 20.20 | 15.02 | 13.44 | 44.16 | 50.09 | 40.62 |
| Alkem Laboratories | -4.20 | 4.14 | -4.99 | -4.93 | -8.92 | 5.79 | 8.36 |
| Biocon | -1.74 | 6.17 | -13.52 | -15.17 | -14.26 | 15.44 | -0.29 |
| Abbott India | -2.21 | -1.22 | -4.00 | -8.61 | -14.03 | 2.11 | 5.43 |
| Gland Pharma | -1.40 | 6.20 | 12.46 | 48.90 | 79.65 | 25.44 | -1.22 |
| Anthem Biosciences | -4.39 | 13.27 | 2.82 | 15.93 | 38.93 | 7.83 | 4.63 |
| Ipca Laboratories | -4.20 | 2.31 | -1.74 | 12.80 | 30.47 | 20.54 | 12.31 |
| GlaxoSmithKline Pharmaceuticals | -3.65 | 5.51 | -8.89 | 9.95 | 5.59 | 16.84 | 9.93 |
| Emcure Pharmaceuticals | 4.41 | 32.25 | 24.28 | 38.52 | 71.61 | 19.77 | 11.43 |
Source: Dion Global
Over the last one year, Sai Life Science has gained 107.31% compared to peers like Sun Pharmaceutical Industries (6.40%), Divi's Laboratories (70.96%), Torrent Pharmaceuticals (22.27%). From a 5 year perspective, Sai Life Science has outperformed peers relative to Sun Pharmaceutical Industries (18.82%) and Divi's Laboratories (18.24%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,837.71 | 1,840.97 |
| 10 | 1,698.73 | 1,774.42 |
| 20 | 1,563.3 | 1,679.72 |
| 50 | 1,560.67 | 1,573.38 |
| 100 | 1,445.52 | 1,465.02 |
| 200 | 1,232.99 | 1,303.48 |
Source: Dion Global
In the latest quarter, Sai Life Science saw a drop in promoter holding to 34.51%, while DII stake decreased to 32.32%, FII holding rose to 19.91%, and public shareholding moved up to 13.25% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 65,63,832 | 1.33 | 1,022.32 | |
| 56,57,345 | 5.4 | 881.13 | |
| 42,83,799 | 5.36 | 667.2 | |
| 40,83,106 | 1.21 | 635.94 | |
| 37,67,826 | 3.71 | 586.84 | |
| 37,02,004 | 1.97 | 576.59 | |
| 26,79,487 | 2.42 | 417.33 | |
| 23,55,745 | 4.04 | 366.91 | |
| 14,75,348 | 6.17 | 229.79 | |
| 12,63,192 | 3.35 | 196.74 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 14, 2026, 03:16 AM IST IST | Sai Life Science - Announcement under Regulation 30 (LODR)-Credit Rating |
| Nov 12, 2026, 04:43 PM IST IST | Sai Life Science - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 12, 2026, 04:36 PM IST IST | Sai Life Science - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| Nov 06, 2026, 08:32 PM IST IST | Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 06, 2026, 05:47 AM IST IST | Sai Life Science - Announcement under Regulation 30 (LODR)-Investor Presentation |
Source: Dion Global
Sai Life Science Ltd. is a Public Limited Listed company incorporated on 25/01/1999 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is U24110TG1999PLC030970 and registration number is 030970. Currently Company is involved in the business activities of Scientific research and development. Company's Total Operating Revenue is Rs. 2153.23 Cr. and Equity Capital is Rs. 21.18 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sai Life Science is ₹1,790.35 as on Nov 18, 2026.
The Sai Life Science is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Sai Life Science is ₹38,059.39 Cr as on Nov 18, 2026.
Today’s highest and lowest price of Sai Life Science are ₹1,819.20 and ₹1,740.90.
The 52-week high/low is the highest and lowest price at which Sai Life Science stock has traded in the past 52-week or nearly a year. The 52-week high of Sai Life Science is ₹1,955.00 and 52-week low of Sai Life Science is ₹786.15 as on Nov 18, 2026.
The Sai Life Science has shown returns of 2.22% over the past day, 28.14% for the past month, 24.45% over 3 months, 107.31% over 1 year, 32.75% across 3 years, and 18.53% over 5 years.
P/E ratio of and PB ratio of Sai Life Science are 101.16 and 14.88 on Nov 18, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global